Blood cancer arises from abnormal blood cell production in the bone marrow, disrupting normal function. Early detection ...

Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

Cero will use Invivoscribe's multiparametric flow cytometry assay to detect minimal residual disease in patients and evaluate the therapy's efficacy.

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...

Planned C-section births may increase the risk of childhood leukemia, particularly B-cell acute lymphoblastic leukemia, with ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.